Antiplatelet effect of 50-mg maintenance dose of Clopidogrel compared to 200 mg ticlopidine: A preliminary study

Heart and Vessels

Volumn 25, Issue 1, 2010, Pages 35-40

  Fukushima, Kenichi ^a   Kobayashi, Yoshio ^a   Kitahara, Hideki ^a   Iwata, Yo ^a   Kuroda, Nakabumi ^a   Ooyama, Masayuki ^a   Kuwabara, Yoichi ^a   Nomura, Fumio ^a   Komuro, Issei ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

Antiplatelet therapy; Stent; Stent thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRATE; TICLOPIDINE; ANTITHROMBOCYTIC AGENT; DIAGNOSTIC AGENT; DRUG DERIVATIVE;

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CONTROLLED STUDY; CORONARY STENT; DRUG EFFICACY; FEMALE; FOLLOW UP; HOSPITAL READMISSION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; JAPANESE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STABLE ANGINA PECTORIS; STENT THROMBOSIS; THROMBOCYTE AGGREGATION; THROMBOCYTE AGGREGATION INHIBITION; TREATMENT INDICATION; TREATMENT OUTCOME; UNSTABLE ANGINA PECTORIS; ASIAN; BLOOD; COMPARATIVE STUDY; CORONARY ARTERY DISEASE; DOSE RESPONSE; DRUG EFFECT; ETHNOLOGY; INSTRUMENTATION; JAPAN; MIDDLE AGED; PILOT STUDY; STENT; THROMBOSIS; TIME; TRANSLUMINAL CORONARY ANGIOPLASTY;

ADENOSINE DIPHOSPHATE; AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ASIAN CONTINENTAL ANCESTRY GROUP; CORONARY ARTERY DISEASE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; JAPAN; MALE; MIDDLE AGED; PILOT PROJECTS; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; STENTS; THROMBOSIS; TICLOPIDINE; TIME FACTORS; TREATMENT OUTCOME;

EID: 77951876460     PISSN: 09108327     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00380-009-1161-2     Document Type: Article

References (10)

1. Moussa I, Oetgen M, Roubin G, Colombo A, Wang X, Iyer S, Maida R, Collins M, Kreps E, Moses JW (1999) Effectiveness of Clopidogrel and aspirin versus ticlopidine and aspirin in preventing stent thrombosis after coronary stent implantation. Circulation 99:2364-2366 (Pubitemid 29218228)
2. Fukushima K, Kobayashi Y, Okuno T, Nakamura Y, Sakakibara M, Nakayama T, Kuroda N, Miyazaki A, Shimizu Y, Komuro I (2007) Incidence of side-effects of ticlopidine after sirolimuseluting stent implantation. Circ J 71:617-619
3. Taniuchi M, Kurz HI, Lasala JM (2001) Randomized comparison of ticlopidine and Clopidogrel after intracoronary stent implantation in a broad patient population. Circulation 104:539-543 (Pubitemid 32738122)
4. Ikeda Y, Uchiyama S, Yamaguchi T, Kawai Y, Nakashima M (2003) Inhibition of platelet aggregation by Clopidogrel sulfate (in Japanese). Jpn J Thromb Hemostasis 14:326-336
5. Kitahara H, Kobayashi Y, Fujimoto Y, Nakamura Y, Nakayama T, Kuroda N, Himi T, Miyazaki A, Komuro I (2007) Late stent thrombosis in patients receiving ticlopidine and aspirin after sirolimus-eluting stent implantation. Circ J 72:168-169
6. Asano T, Kobayashi Y, Fukushima K, Iwata Y, Kitahara H, Ishio N, Kuroda N, Komuro I (2008) Safety and efficacy of low-dose Clopidogrel in Japanese patients undergoing coronary stenting: preliminary 30-day clinical outcome. Circ J 72:1707-1708
7. Gurbel PA, Bliden KP, Hiatt BL, O'Connor CM (2003) Clopidogrel for coronary stenting. Circulation 107:2908-2913
8. Buonamici P, Marcucci R, Migliorini A, Gensini GF, Santini A, Paniccia R, Moschi G, Gori AM, Abbate R, Antoniucci D (2007) Impact of platelet reactivity after Clopidogrel administration on drug-eluting stent thrombosis. J Am Coll Cardiol 49:2312-2317 (Pubitemid 46891710)
9. Murasaki S, Murasaki K, Tanoue K, Kawana M, Hagiwara N, Kasanuki H (2007) Circulating platelet and neutrophil activation correlates with the clinical course of unstable angina. Heart Vessels 22:376-382 (Pubitemid 350201432)
10. Horii M, Uemura S, Uemura M, Matsumoto M, Ishizashi H, Imagawa K, Iwama H, Takeda Y, Kawata H, Nakajima T, Fujimura Y, Saito Y (2008) Acute myocardial infarction as a systemic prothrombotic condition evidenced by increased von Willebrand factor protein over ADAMTS13 activity in coronary and systemic circulation. Heart Vessels 23:301-307